Biochemical Science Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, USA.
Cancer Lett. 2012 Dec 31;327(1-2):26-47. doi: 10.1016/j.canlet.2012.01.016. Epub 2012 Jan 28.
Endogenous and exogenous sources cause oxidatively induced DNA damage in living organisms by a variety of mechanisms. The resulting DNA lesions are mutagenic and, unless repaired, lead to a variety of mutations and consequently to genetic instability, which is a hallmark of cancer. Oxidatively induced DNA damage is repaired in living cells by different pathways that involve a large number of proteins. Unrepaired and accumulated DNA lesions may lead to disease processes including carcinogenesis. Mutations also occur in DNA repair genes, destabilizing the DNA repair system. A majority of cancer cell lines have somatic mutations in their DNA repair genes. In addition, polymorphisms in these genes constitute a risk factor for cancer. In general, defects in DNA repair are associated with cancer. Numerous DNA repair enzymes exist that possess different, but sometimes overlapping substrate specificities for removal of oxidatively induced DNA lesions. In addition to the role of DNA repair in carcinogenesis, recent evidence suggests that some types of tumors possess increased DNA repair capacity that may lead to therapy resistance. DNA repair pathways are drug targets to develop DNA repair inhibitors to increase the efficacy of cancer therapy. Oxidatively induced DNA lesions and DNA repair proteins may serve as potential biomarkers for early detection, cancer risk assessment, prognosis and for monitoring therapy. Taken together, a large body of accumulated evidence suggests that oxidatively induced DNA damage and its repair are important factors in the development of human cancers. Thus this field deserves more research to contribute to the development of cancer biomarkers, DNA repair inhibitors and treatment approaches to better understand and fight cancer.
内源性和外源性来源通过多种机制在生物体中引起氧化性诱导的 DNA 损伤。由此产生的 DNA 损伤是诱变的,如果不修复,会导致多种突变,进而导致遗传不稳定性,这是癌症的标志。在活细胞中,氧化性诱导的 DNA 损伤通过涉及大量蛋白质的不同途径进行修复。未修复和积累的 DNA 损伤可能导致包括癌变在内的疾病过程。DNA 修复基因也会发生突变,使 DNA 修复系统不稳定。大多数癌细胞系的 DNA 修复基因都存在体细胞突变。此外,这些基因中的多态性构成了癌症的风险因素。一般来说,DNA 修复缺陷与癌症有关。存在许多具有不同但有时重叠的底物特异性的 DNA 修复酶,用于去除氧化性诱导的 DNA 损伤。除了 DNA 修复在致癌作用中的作用外,最近的证据表明,某些类型的肿瘤具有增加的 DNA 修复能力,这可能导致治疗耐药性。DNA 修复途径是开发 DNA 修复抑制剂的药物靶点,以提高癌症治疗的疗效。氧化性诱导的 DNA 损伤和 DNA 修复蛋白可以作为早期检测、癌症风险评估、预后和监测治疗的潜在生物标志物。综上所述,大量积累的证据表明,氧化性诱导的 DNA 损伤及其修复是人类癌症发展的重要因素。因此,这个领域值得进一步研究,以促进癌症生物标志物、DNA 修复抑制剂和治疗方法的发展,从而更好地理解和对抗癌症。